Life sciences company lobbying feds for support for psilocybin-assisted therapy clinical trial
Michael Kydd, a consultant with Kydder Management Group Inc., registered this past week to lobby on behalf of Halucenex Life Sciences.
Stay updated with breaking news from Halucenex Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Kydd, a consultant with Kydder Management Group Inc., registered this past week to lobby on behalf of Halucenex Life Sciences.
Melodiol Global Health Ltd (ASX:ME1) is moving to streamline its portfolio and expand its North American footprint through an asset sale with US-listed...
A surprise ruling by the Therapeutic Goods Administration has opened the way for drug companies to tap a new market for psychedelic treatments
Australia's world-first legalisation of psychedelic treatments for mental health conditions has companies pursuing a market opportunity to do...
Australia's world-first legalisation of psychedelic treatments for mental health conditions has companies pursuing a market opportunity to do...